With 3 days of jam-packed content and 32+ digital health expert speakers, the 2^nd Digital Biomarkers & Clinical Measures in Neuro Summit is biopharma’s can’t-miss meeting for the innovation, validation, and acceptance of digital biomarkers endpoints in CNS pipelines.

Join 80+ of your digital health and CNS clinical development peers to address the standardization and regulatory acceptance of digital tools and data analysis as endpoints in complex neurological indications, discover novel innovations for objective, sensitive, and non-invasive neurological measures, and ensure internal confidence and scalability with emerging digital technologies.

What’s New for 2023?

• Brand-New Presenting Pharma Companies: Network and hear from new experts from Regeneron, Lundbeck, AbbVie, Pfizer, and Servier, showcasing their latest work developing novel digital measures and devices to sensitively and objectively tackle neurological indications.
• 12 Hours of Pre-Conference Workshop Content: With 2 workshop streams dedicated to data scientists and neurology translational scientists, join these 3-hour interactive sessions to deep-dive into the latest innovations in big data analysis, data standardization, regulatory requirements, and industry confidence and scalability.
• Patient Advocate Discussion: Hear directly from patients and advocates involved in digital measure clinical research to understand the patient perspective on meaningful digital measure development and remote trial participation.